Michael Grabner

Summary

Affiliation: Health Outcomes Research
Country: USA

Publications

  1. ncbi Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population
    Michael Grabner
    HealthCore, 123 Justison St, Ste 200, Wilmington, DE 19801
    J Manag Care Spec Pharm 21:1204-12. 2015
  2. doi Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial
    Michael Grabner
    HealthCore, Inc, Wilmington, DE 19801, USA
    Postgrad Med 125:204-13. 2013

Detail Information

Publications3

  1. ncbi Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population
    Michael Grabner
    HealthCore, 123 Justison St, Ste 200, Wilmington, DE 19801
    J Manag Care Spec Pharm 21:1204-12. 2015
    ..Approved less than 2 years ago, use of canagliflozin is largely uncharacterized...
  2. doi Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial
    Michael Grabner
    HealthCore, Inc, Wilmington, DE 19801, USA
    Postgrad Med 125:204-13. 2013
    ....